PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, University of Otago, Wellington, New Zealand.\', \'Division of Rheumatology, Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.\', \'Department of Rheumatology, St James\'s Hospital, Dublin, Ireland.\', \'Division of Rheumatology, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA, USA.\', \'University of Queensland School of Clinical Medicine, Faculty of Medicine, Herston, Queensland, Australia. philip.robinson@uq.edu.au.\', \'Royal Brisbane & Women\'s Hospital, Metro North Hospital & Health Service, Herston Road, Herston, Queensland, Australia. philip.robinson@uq.edu.au.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41584-022-00755-x
?:doi
?:hasPublicationType
?:journal
  • Nature reviews. Rheumatology
is ?:pmid of
?:pmid
?:pmid
  • 35217850
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all